A 10-aa motif in transmembrane helix 1 of diphtheria toxin that is conserved in anthrax edema factor, anthrax lethal factor, and botulinum neurotoxin serotypes A, C, and D was identified by BLAST, CLUSTAL W, and MEME computational analysis. Using the diphtheria toxin-related fusion protein toxin DAB 389IL-2, we demonstrate that introduction of the L221E mutation into a highly conserved residue within this motif results in a nontoxic catalytic domain translocation deficient phenotype. To further probe the function of this motif in the process by which the catalytic domain is delivered from the lumen of early endosomes to the cytosol, we constructed a gene encoding a portion of diphtheria toxin transmembrane helix 1, T1, which carries the motif and is expressed from a CMV promoter. We then isolated stable transfectants of Hut102͞6TG cells that express the T1 peptide, Hut102͞6TG-T1. In contrast to the parental cell line, Hut102͞6TG-T1 cells are ca. 10 4 -fold more resistant to the fusion protein toxin. This resistance is completely reversed by coexpression of small interfering RNA directed against the gene encoding the T1 peptide in Hut102͞ 6TG-T1 cells. We further demonstrate by GST-DT140-271 pull-down experiments in the presence and absence of synthetic T1 peptides the specific binding of coatomer protein complex subunit ␤ to this region of the diphtheria toxin transmembrane domain.
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early endosomes ͉ translocation ͉ ADP-ribosyltransferase ͉ coatomer protein complex subunit ␤ T he intoxication of eukaryotic cells by diphtheria toxin follows an ordered series of interactions between the toxin and cellular factors that lead to inhibition of protein synthesis and cell death (1) . Biochemical, genetic, and x-ray crystallographic analysis of the toxin has shown the protein to be composed of three distinct domains: an N-terminal catalytic (C) domain, a central transmembrane (T) domain, and the C-terminal receptor-binding domain (2) (3) (4) (5) . The intoxication process is initiated by the binding of the toxin to its cell surface receptor, a heparin binding epidermal growth factor-like precursor, and CD9 (6, 7) . Once bound to its receptor, the toxin is internalized by receptormediated endocytosis into an early endosomal compartment (8) . Upon acidification of the endosomal lumen by vesicular ATPase, the T domain undergoes a conformational change and spontaneously inserts into the vesicular membrane, forming an 18-to 22-Å pore or channel (9, 10) . It is widely believed that the C domain, in a fully denatured form, is specifically thread through this channel and released into the cytosol. Once the C domain is refolded into an active conformation, it catalyzes the NAD ϩ -dependent ADP ribosylation of elongation factor 2 (EF-2), causing irreversible inhibition of protein synthesis and death of the cell by apoptosis (11, 12) . Although the endosomal membrane translocation of the C domain is understood in broad terms, the precise molecular mechanism(s) of this step in the intoxication process has remained largely unknown.
Two hypotheses for C domain translocation across the endosomal vesicle membrane have been suggested. Oh et al. (13) and Ren et al. (14) have proposed recently that C domain translocation across synthetic planar lipid membranes is autonomous and occurs in an unassisted manner. In contrast, Lemichez et al. (15) and Ratts et al. (16) have proposed that C domain translocation from the lumen of purified early endosomes to the external milieu requires cytosolic factors. In these studies, an in vitro system composed of partially purified early endosomes that were preloaded with either diphtheria toxin or the fusion protein toxin DAB 389 IL-2 in the presence of the vesicular ATPase inhibitor Bafilomycin A1 were used in an in vitro assay system. Removal of Bafilomycin and the addition of ATP to the reaction mixture results in the acidification of the early endosomal lumen; however, translocation of the C domain to the external milieu requires the addition of a cytosolic translocation factor (CTF) complex (16) .
Because the in vitro translocation of the diphtheria toxin C domain from the lumen of early endosomes appears to require cellular factors, we reasoned that there might be a specific motif carried on either the C-terminal end of the catalytic domain or the N-terminal end of the T domain that interacts with one or more components of the CTF complex and facilitates the entry process. In the present work, we show that a 21-aa peptide, T1, containing a conserved 10-aa motif (amino acids 215-224), in the transmembrane domain plays an essential role in the process by which the C domain is translocated from the lumen of early endosomes. Mutation of a highly conserved leucine, L221 in the fusion protein toxin DAB 389 IL-2, that is centrally positioned in the motif to glutamate results in a translocation-deficient phenotype (Note: amino acid numbering of DAB 389 IL-2 is ϩ1 relative to native diphtheria toxin because of an N-terminal methionine residue on this protein). Expression of the T1 peptide containing this motif in stable transfectants of Hut102͞ 6TG cells confers resistance to the fusion protein toxin DAB 389 IL-2 and native diphtheria toxin but not to Pseudomonas exotoxin A, which is known to enter the cytosol after retrotransport to the endoplasmic reticulum (17) . In addition, we show that coexpression of short interfering RNA (siRNA) directed against the gene encoding the T1 peptide in Hut102͞6TG-T1 cells results in restoration of sensitivity to DAB 389 IL-2 action. Finally, using GST-DT140-271 as bait in pull-down experiments, we demonstrate the binding of coatomer protein complex subunit ␤ (␤-COP) to a region of diphtheria toxin that at least overlaps the T1 peptide. Results presented here suggest that small molecule inhibitors of the interaction between ␤-COP and the T1 peptide on diphtheria toxin may be prototypes of a previously uncharacterized class of cytosolic antitoxins that block toxin entry.
Experimental Procedures
In Vitro Translocation Assay. Translocation of the diphtheria toxin C domain from the lumen of purified early endosomes to the external medium was performed as described by Ratts et al. (16) . Early endosomes were isolated from Hut102͞6TG cells as described by . Before isolation, the endosomal compartment was preloaded with either 1 M DAB 389 IL-2 or DAB 389 (L221E)IL-2, and͞or 8 mg͞ml 70-kDa OG 551-dextran conjugate (Molecular Probes) by using 1 M Bafilomycin A1-primed cells (LC Laboratories).
ADP-Ribosyltransferase Assay. ADP-ribosyltransferase assays were performed with a procedure modified from Chung and Collier (19) . Briefly, the reaction mixture contained 20 mM Hepes-KOH (pH 7.4), 1 mM Mg(OAc) 2 , 110 mM KOac, 1 mM DTT, 0.13 mg͞ml purified EF-2, 1.2 pmol [
32 P]-NAD ϩ (PerkinElmer), and either translocation mixture supernatant fluid or pellet fractions. Reaction mixtures were analyzed by electrophoresis on 7% SDS-polyacrylamide gels at 120 V for 2 h. Gels were then dried and autoradiographed.
Construction of pTRACER-T1 and pRR-XT1 Vectors. The pTRACER-CMV2 expression vector was obtained from Invitrogen. The oligonucleotide primers used for the PCR amplification of amino acids 210-229, T1 peptide, from DAB 389 IL-2 are as follows: 5Ј-CCGGAATTCTATACCATGCGTGATAAAACTAAAAC-TAAG-3Ј and 3Ј-CTTGTGCCAGGCTAGTTTTTGTTTATCA-GATCTATC-5Ј. The oligonucleotide encoding the 5Ј end of the construct was modified to include an EcoR1 restriction endonuclease site, a Kozak signal (20) , and an ATG translation initiation signal. The oligonucleotide encoding the 3Ј end of the sequence included a translation termination signal, and an XbaI site. After PCR amplification, the oligonucleotides were annealed, digested with EcoR1 and XbaI, and ligated into the EcoR1 and XbaI sites of the pTRACER-CMV2 vector. The predicted amino acid sequence for the T1 peptide is as follows: MRDKTKTKIESLKEH-GPIKNK.
The pRR-XT1 vector was constructed from the psiRNAhH1neo vector (Invivogen) by ligating the SirF͞SirR doublestranded oligonucleotides into the BglI restriction endonuclease site. The SirF oligonucleotide (5Ј-TCCCACACTAAGATC-GAATCTCTGATCAAGAGATCAGAGATTCGATCTTA-3Ј) was annealed to the SirR oligonucleotide (3Ј-ATTCTAGCTTA-GAGACTAGTTCTCTAGTCTCTAAGCTAGAATCAAA AAC-5Ј) under standard conditions. After annealing and ligation into the BglI site of psiRNA-hHneo vector, Escherichia coli 6T116 was transformed, single colonies were isolated, and their plasmid DNAs were sequenced to ensure insertion of the siRNA-encoding oligonucleotides.
PCR Detection of mRNA Transcripts Encoding the T1 Motif Peptide.
Total RNA was extracted from Hut102͞6TG and Hut102͞6TG-T1 cells according to standard methods, and the Superscript III first-strand system was used for RT-PCR (Invitrogen). Oligonucleotide primers used for detection of T1 peptide mRNA are as follows: forward T1 primer: 5Ј-CCATGAGTGATAAAAC-TAAA-3Ј; reverse T1 primer: 5Ј-ATTAGGAAAGGACAGT-GGGA-3Ј.
T1 and Control Peptides. The synthetic T1 peptide containing the 10 amino acid motif (underlined), RDKTKTKIESLKEHGPIKNS, was synthesized and purified to 91.3% by high performance liquid chromatography by 21st Century Biochemicals (Marlboro, MA). This peptide has a molecular mass of 2,351 Da and a pI of 9.8. A 2,335-Da molecular mass peptide with the sequence AENSD-KHRIMQVFHRTLNQ and pI of 8.8 was used as a negative control in GST-DT140-271 pull-down experiments.
Cytotoxicity Assays. Cytotoxicity assays were performed essentially as described by vanderSpek et al. (21) .
Genetic Construction of GST-DT140 -271. The oligonuleotide primers used to amplify diphtheria tox gene sequences encoding amino acids 140 to 271 were as follows: 5Ј-CGCGGATC-CCCCTTCGCTGAGGGGAGT-3Ј and 3Ј-CCGCTCGAG-CGGGTTGGTACCAGTAAC-5Ј. The oligonucleotide sequences also introduced BamHI and XhoI restriction endonuclease sites on the 5Ј and 3Ј ends of the amplicon, respectively.
After amplification and digestion with BamHI and XhoI, the doubled-stranded DNA was cloned into the corresponding sites in pGEX-4T-1 to form pGEX-DT-T1.
GST and GST-DT140 -271 Protein Column Preparation. GST and the fusion protein GST-DT140-271 were expressed in E. coli strain BL-21(DE-3) transformed with either pGEX-T4-1 or pGEX-DT-T1 and purified as described in ref. 22 . Protein concentrations were determined by the modified Bradford reagent (BioRad). After purification, GST and GST-DT140 -271 were separately incubated with glutathione Sepharose beads (1 ml of GS beads per mg of recombinant protein) at 4°C for 2 h in PBS.
Hut102͞6TG Cell Lysate Preparation and GST-Pull Down. Hut102͞ 6TG cells were resuspended in hypotonic buffer (10 mM Tris⅐HCl, pH 7.3͞10 mM KCl͞1.5 mM MgCl 2 ͞1 mM EDTA͞1 mM DTT) and incubated at 4°C for 30 min. The cells were homogenized, and the resulting lysate was centrifuged at 100,000 ϫ g for 1 h and then dialyzed with buffer A (30 mM Tris⅐HCl, pH 7.4͞5 mM MgCl 2 ͞1 mM EDTA͞1 mM DTT). Equal volumes of dialyzed cytoplasmic lysate were passed separately through GST and GST-DT columns. Proteins bound to the columns were eluted and fractionated with 1 ml of buffer C (buffer A plus 500 mM NaCl). The fractions containing interacting proteins were then analyzed by electrophoresis on SDS͞ PAGE gels, followed by silver staining.
Protein Identification by Mass Spectrometry Sequencing. After SDS͞PAGE, proteins were digested in situ with trypsin as described in refs. 23 and 24. Tryptic peptides were analyzed by MALDI-TOF-MS (Voyager DE-PRO, Applied Biosystems, Framingham, MA) and electrospray ionization mass spectrometry (ESI-MS). ESI-MS and MS͞MS were performed by using an electrospray ion trap, LCQ-DECA (Thermo Electron). The tryptic peptides were fractionated on a capillary HPLC C-18 column coupled with a mass spectrometer. Tandem mass spectra were acquired by using Ar as the collision gas and sufficient collision energy to obtain complete sequence information of the precursor ion. MS and MS͞MS data were then analyzed by BIOWORKS 3.0 software package (Thermo Electron).
In Vitro Synthesis of ␤-COP in Rabbit Reticulocyte Lysates. The structural gene encoding ␤-COP was purchased from OriGene Technologies (Rockville, MD). The full-length gene was cloned into pCMV6-XL5 mammalian vector to form pAB157 according to standard methods. Full length ␤-COP (110,000 Da) was synthesized in vitro by using the TNT Quick Coupled Transcription͞Translation System (Promega) in the presence of [ 35 S]methionine. After in vitro synthesis, the reaction mixture was diluted with binding buffer (50 mM Tris⅐HCl, pH 7.4͞150 mM NaCl͞1 mM EDTA͞1% Nonidet P-40͞a protease inhibitor mixture). Pull-down experiments with GST and GST-DT140-271 were performed as described above.
Results and Discussion
Nontoxic mutants of diphtheria toxin generally have fallen into one of three categories: point mutants that no longer catalyze the NAD ϩ -dependent ADP-ribosylation of EF-2 (e.g., CRM197; ref.
25), premature chain termination mutants that are ADPribosyltransferase-positive but no longer capable of binding to the eukaryotic cell surface receptor for the toxin (e.g., CRM45, ref. 25) , and transmembrane domain mutants that are unable to form pores in lipid membranes (26) . In rare instances, mutants that fall outside of these three classes have been reported. vanderSpek et al. (21) described a transmembrane helix 1 point mutant, DAB 389 (L221E)IL-2, that was both ADP-ribosyltransferase positive and bound to the targeted high affinity IL-2 receptor with an affinity equal to that of the wild-type fusion protein. Because DAB 389 (L221E)IL-2 might define a translocation-deficient phenotype, we further characterized the interaction between DAB 389 (L221E)IL-2 and Hut102͞6TG cells by using fusion toxin preloaded early endosomes in the in vitro translocation assay (16) . In these experiments, early endosomes in Hut102͞6TG cells were separately preloaded with either DAB 389 IL-2 or DAB 389 (L221E)IL-2 in the presence of Bafilomycin A1. Cells were lysed and early endosomes were partially purified by sucrose density centrifugation as described in refs. 15 and 16. Upon removal of Bafilomycin A1 and the addition of both ATP and partially purified CTF complex, we measured translocation and release of the C domain from the endosomal lumen to the external milieu by determination of ADPribosyltransferase activity in both the pellet and supernatant fluid fractions after ultracentrifugation (180,000 ϫ g for 20 min at 4°C). As shown in Fig. 1A , by densitometric analysis, Ϸ60% of the ADP-ribosyltransferase activity from the wild-type DAB 389 IL-2 is translocated from the endosomal lumen to the supernatant fluid fraction in the 30-min incubation period. In marked contrast, essentially all of the ADP-ribosyltransferase activity from DAB 389 (L221E)IL-2 remains in the pellet fraction.
To determine whether the T domain of DAB 389 (L221E)IL-2 was capable of inserting into the vesicle membrane and forming ion conductive channels, we cointernalized the pH-sensitive dye Oregon Green 514 (OG 514) conjugated to high molecular mass dextran (70 kDa) along with the fusion protein toxins into the early endosomal compartment. After sucrose density gradient purification of these vesicles, we monitored the acidic pH quenching of the OG 514 fluorescent signal upon addition of ATP to the reaction mixture (Fig. 1B) . In the case of early endosomes that were preloaded with OG 514-dextran alone, after the removal of Bafilomycin A1 and the absence of added ATP, the fluorescent signal remains constant. As anticipated, the addition of ATP to the reaction mixture causes a progressive quenching of the fluorescent signal with time as the lumen of early endosomes becomes acidified through the action of the vesicular ATPase proton pump (Fig. 1B) . Cointernalization of OG 514-dextran with either DAB 389 IL-2 or DAB 389 (L221E)IL-2 into early endosomes, followed by the addition of ATP to the reaction mixture, results in the identical quenching of the fluorescent signal. In both instances, increased quenching of the fluorescent signal is seen for the first 5 min, after which the signal plateaus (Fig. 1B) , presumably because of an equilibration of the luminal pH due to an influx of protons into the endosomal lumen through the continuous action of the vesicular ATPase proton pump and the efflux of protons to the external milieu through the nascent ion conductive channel formed by the T domain. Taken together, these results suggest that both the wild-type and mutant fusion protein toxins are capable of forming ion conductive channels in the endosomal vesicular membrane. As a result of these observations, we conclude that the noncytotoxic phenotype of DAB 389 (L221E)IL-2 is due to a specific defect in C domain translocation from the vesicular lumen to the cytosol of target cells.
Because Ratts et al. (16) demonstrated that a CTF complex was essential for the translocation and release of the C domain from purified early endosomes, we reasoned that either the C or T domain of the toxin might carry a specific motif that provides an essential direct or indirect interaction with one or more of the components of this complex in the C domain entry process. We compared by BLAST (27) and CLUSTAL W alignment (28) analysis 12-aa overlapping sequences of diphtheria toxin against the sequence of other bacterial protein toxins. As shown in Table 1 , the results of this analysis, coupled with the MEME (Multiple Expectation maximization for Motif Elucidation; ref. 29) computational search tool indicate a statistically significant conserved 10-aa peptide motif present in transmembrane helix 1 of diphtheria toxin with decamer sequences in anthrax lethal and edema factors, as well as the botulinum neurotoxin serotypes A, C, and D (see Fig. 5 , which is published as supporting information on the PNAS web site). Each of these bacterial protein toxins is known to employ a similar route of entry into the cell, and all require passage through an acidified early endosomal compartment to deliver their respective catalytic domains into the cytosol (11, 30, 31) . We also noted that this motif is positioned in a region of each of these protein toxins that is consistent with their early emergence on the cytosolic side of the endosomal membrane upon translocation through the channel formed by their respective T domains or, in the case of anthrax lethal and edema factors, the pore formed by protective antigen. It is of particular interest to note that the L221E mutation in Fig. 1 . The nontoxic point mutant DAB389(L221E)IL-2 is receptor-binding competent, enzymatically active, and pore-forming competent, but its C domain fails to be translocated from the lumen of purified early endosomes in vitro. (A) ADP-ribosyltransferase activity of supernatant fluid and lysed pellet fractions after in vitro translocation of the diphtheria toxin C domain from purified early endosomes. The early endosomal compartment of Hut102͞6TG cells was separately preloaded with either wild-type DAB 389IL-2 or DAB 389(L221E)IL-2 in the presence of Bafilomycin A1. After cell lysis and partial purification of early endosomes by sucrose density gradient centrifugation, the translocation of the C domain from the vesicle lumen to the external milieu was determined after the addition of ATP and partially purified CTF. After ultracentrifugation to pellet endosomes, ADP-ribosyltransferase activity associated with the lysed pellet (P) and supernatant fluid (S) fractions was monitored by autoradiography of [ 32 
P]-labeled ADPR-EF-2. (B)
The early endosomal compartment in Hut102͞6TG cells was preloaded with OG 514 conjugated to 70-kDa dextran in the absence or presence of either DAB 389IL-2 or DAB389(L221E)IL-2 in the presence of Bafilomycin A1. After cell lysis and partial purification of the early endosome fraction by sucrose density gradient centrifugation, endosomes preloaded with OG 514 dextran conjugate alone were resuspended in translocation buffer in the absence (OE) or presence (E) of 2 mM ATP. Endosomes that were preloaded with either OG 514 conjugate and DAB 389IL-2 (ᮀ) or OG 514 conjugate and DAB389(L221E)IL-2 ({) were resuspended in translocation buffer in the presence of 2mM ATP. Control purified early endosomes (F). Fluorescence emission was measured at an excitation wavelength of 511 nm and an emission wavelength of 530 nm. Values were compared to 1 ng͞ml OG 514-dextran conjugate at pH 7.5 and 4.5.
DAB 389 IL-2, which gives rise to a translocation-deficient phenotype as described above, is positioned in a highly conserved central residue in the MEME motif. Further, in the case of anthrax lethal factor, the motif is positioned between residues 31-40 in the mature protein, a region that is structurally distinct from the protective antigen binding domain (32) , and N-terminal deletion analysis of anthrax lethal factor has shown previously that this region is required for toxicity (32, 33) . In contrast, this motif was not detected in those protein toxins known to undergo retrograde transport and whose catalytic domains enter the cytosol from the endoplasmic reticulum (e.g., cholera toxin, Shiga toxin, ricin toxin, and Pseudomonas exotoxin A) (17, 34) .
We further examined the potential role of this region of the T domain in mediating delivery of the diphtheria toxin C domain across early endosomal membranes by constructing a gene that encodes a peptide, T1, corresponding to amino acids 210-229 of diphtheria toxin. This minigene was cloned into the pTRACER vector, and stable transfectants of Hut102͞6TG cells were selected in the presence of Zeocin. Insertion of pTRACER-T1 DNA into the genome was phenotypically confirmed by both the constitutive expression of GFP and resistance to Zeocin (data not shown). Individual transfectant cell lines were then isolated by limiting dilution. To demonstrate the presence of mRNA specific for T1 gene expression, total mRNA was partially purified from Hut102͞6TG and Hut102͞6TG-T1 cells and oligonucleotide primers specific for the 5Ј end of the T1 gene and 3Ј end vector sequences were used for PCR amplification. mRNA encoding the T1 peptide was readily detected in extracts of Hut102͞6TG-T1 cells but not in extracts of the parental Hut102͞6TG cell line (see Fig. 6 , which is published as supporting information on the PNAS web site).
Hut102͞6TG and Hut102͞6TG-T1 cells were then examined for their sensitivity to DAB 389 IL-2 by dose-response analysis. As shown in Fig. 2A , the IC 50 for DAB 389 IL-2 in Hut102͞6TG cells was found to be 5 ϫ 10 Ϫ11 M. In marked contrast, the IC 50 for DAB 389 IL-2 in Hut102͞6TG-T1 cells was Ͼ10 Ϫ8 M. Analogous results were obtained when the parental and transfectant cell lines were used in dose-response analysis by using native diphtheria toxin (Fig. 2B) .
Once delivered to the cytosol, the catalytic domains of diphtheria toxin and Pseudomonas exotoxin A inhibit protein synthesis by an identical NAD ϩ -dependent ADP-ribosylation of EF-2; however, the entry of exotoxin A ribosyltransferase is known to occur in the endoplasmic reticulum after retrotransport rather than from acidified early endosomes (17) . We therefore compared the sensitivity of both Hut 102͞6TG and T1-transfected cell lines to Pseudomonas exotoxin A by doseresponse analysis. As shown in Fig. 2C , both cell lines were found to be equally sensitive, IC 50 Ϸ 10 Ϫ8 M. To further demonstrate that expression of the T1 peptide was directly associated with the toxin resistant phenotype, Hut102͞ 6TG-T1 cells were cotransfected with plasmid pRR-XT1, which produces siRNA specific for the knockdown of T1 peptide expression. As shown in Fig. 2 A, coexpression of siRNA directed toward the T1 gene in Hut102͞6TG-T1 cells results in restoration of full sensitivity to DAB 389 IL-2 (IC 50 Ϸ 7 ϫ 10 Ϫ11 M). These results demonstrate that the toxin-resistant phenotype in Hut102͞6TG-T1 cells is directly related to the ongoing expression of the T1 peptide in these target cells. Taken together the above observations strongly support the hypothesis that the T1 peptide within transmembrane helix 1 of diphtheria toxin plays an essential role in the delivery of the C domain from the lumen of acidified early endosomes to the cytosol in vivo. Although other interpretations are possible, the translocation-deficient phenotype of DAB 389 (L221E)IL-2, the resistance of Hut102͞ 6TG-T1 cells to the action of DAB 389 IL-2, and the reversal of fusion toxin resistance by expression of siRNA to knock down T1 peptide expression lead us to conclude that the T1 peptide is likely to bind to and inhibit one or more of the components of the CTF complex.
In an attempt to isolate cytosolic proteins that were capable of binding the T1 peptide, we next constructed a fusion protein between GST and amino acids 140-271 of native diphtheria toxin. Because other regions outside of the T1 peptide might also be important in the entry process, we cloned a larger segment of the diphtheria toxin structural gene in the construction of the GST fusion protein. After expression and purification of the GST-DT140-271 fusion protein from extracts of recombinant E. coli, we performed a series of pull-down experiments in postnuclear supernatant extracts of Hut102͞6TG cells. Fig. 3A shows a silver-stained SDS-polyacrylamide gel after separation of individual proteins that bound to either GST or the GST-DT140-271. We have begun to identify individual proteins that are pulled down by GST-DT140-271 by mass spectrometry sequence analysis. We have identified ␤-COP sequences in both a high molecular mass complex and as a full-length 110,000 Da mono- The 10-aa motif in diphtheria toxin transmembrane helix 1 and related sequences from anthrax edema factor, anthrax lethal factor, and botulinum neurotoxins serotypes A, C, and D were identified in silico by using the Multiple Expectation maximization for Motif Elucidation MEME tool (29) . Blue, A, C, F, I, L, V, W, and M (most hydrophobic); green, N, Q, S, and T (polar noncharged); magenta, D and E (acidic); red, K and R (positively charged); pink, H; orange, G.
mer. As shown by immunoblot analysis with anti-␤-COP antibodies, the monomeric form of ␤-COP is pulled down by GST-DT140-271 (Fig. 3B) . We next asked whether the addition of synthetic T1 peptide to the pull-down mixture would inhibit this interaction. In these experiments, increasing concentrations of T1 peptide were added to postnuclear supernatant extracts of Hut102͞6TG cells and incubated for 1 h at 4°C, GST-DT140-271 was then added and associated proteins were pulled down and analyzed by SDS͞PAGE and immunoblot by using anti-␤-COP. As shown in Fig. 3C , in the presence of increasing concentrations of T1 peptide (0.75-10 M) in the pull-down reaction mixture inhibits the binding of ␤-COP to GST-DT140-271 in a dosedependent manner. In control experiments, a peptide of similar molecular weight and pI as the T1 peptide fails to block the pull down of ␤-COP by GST-DT140-271 (data not shown). Taken together, these results strongly suggest that either a direct or indirect interaction between ␤-COP and DT140-271 requires at least a portion of the T1 peptide sequence.
To demonstrate that the interaction between GST-DT140-271 and ␤-COP was direct, we expressed [
35 S]-labeled ␤-COP in rabbit reticulocyte lysates that were programmed with pAB157 DNA. As shown in Fig. 4 , after in vitro synthesis and the addition of either GST or GST-DT140-271 to the reaction mixture, only GST-DT140-271 was found to pull down [ 35 S]-labeled ␤-COP. These results suggest that the interaction between the GST-DT140-271 and ␤-COP is likely to be direct and not mediated through an accessory protein that might have been bound to ␤-COP in Hut 102͞6TG cell extracts. These results confirm and extend the observations of Lemichez et al. (15) , who demon- strated that the addition of anti-␤-COP blocked diphtheria toxin C domain translocation from the lumen of purified early endosomes to the external milieu. Taken together, we conclude that ␤-COP is likely to function as a component of the CTF complex in the diphtheria toxin C domain entry process.
At present, we have not constructed the appropriate vectors or cell lines to test whether expression of the T1 peptide will also confer resistance to anthrax lethal factor, anthrax edema factor, or the botulinum neurotoxins. Nonetheless, it is of interest to note that Abrami et al. (35) , using partially purified early and late endosomes, have recently demonstrated that PA heptmer inserts into the membrane of early endosomes and that translocation of anthrax lethal factor to the cytoplasm occurs later in the endocytic vesicle pathway. Arora and Lepplea (36) demonstrated that the deletion of amino acids 1-40 of lethal factor results in a complete loss of toxicity for macrophages. Recently, Zhang et al. (37) found that the deletion of the N-terminal 27-to 36-aa residues from lethal factor inhibited acid-triggered translocation to the cytosol of target cells. Because these regions encompass the MEME motif in lethal factor, it is tempting to speculate that these sequences may play a role in the translocation process.
Results reported here suggest that the interaction between ␤-COP and diphtheria toxin sequences that include at least a portion of the T1 peptide is likely to be an early event in the catalytic domain entry process. We are currently testing the hypothesis that emergence of T1 sequences on the cytosolic side of the early endosomal membrane may initially interact with ␤-COP or COPI. The interaction between the toxin and the CTF complex in the entry process is essential and raises the question of whether localized budding of the early endocytic vesicle membrane (38) plays a role in the process by which the diphtheria toxin C domain is delivered to the cytosol of target cells. Fig. 4 . Incubation of either GST or GST-DT140-271 with rabbit reticulocyte lysate extracts supplemented with [ 35 S]methionine after the coupled transcription translation of plasmid pAB157 DNA that encodes ␤-COP. After pull-down reactions, the 500 mM NaCl eluates from GST and GST-DT140-271 were electrophoresed in SDS-polyacrylamide gels and autoradiographed. Lane 1, total input protein from coupled in vitro transcription and translation of pAB157 DNA; lane 2, GST pull-down reaction; lane 3, GST-DT140-271 pull-down reaction.
